Skip to content

Roivant Sciences ROIV Cash Flow Statement

FY'25FY'24FY'23FY'22
-$318.93M-107%$4.41B+496%-$1.12B-20.7%
$3.35M-76.2%$14.07M-36.1%$22.04M+16.9%$18.86M
$346.17M+19.8%$289.03M+44.8%$199.63M-8.3%$217.78M-61.5%
-$750.35M+10.6%-$839.45M-9.7%-$765.27M+9.3%-$843.39M-24.4%
$4.6M+233%$1.38M-89.1%$12.69M-27.2%
$5.2B
$1.29B$0$0
-$1.22B-370%$451.99M-10.8%$506.8M+60.8%
$4.99B
-$758.56M+10.1%-$844.05M-10.1%-$766.65M+10.4%-$856.08M-23.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Roivant Sciences generate?
Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
What is Roivant Sciences's free cash flow?
After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
Where does Roivant Sciences's cash flow data come from?
Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.